SelectQuote Inc
SLQT2.080USD
+0.060+2.97%
Close 08/13, 16:00（ET）Quotes delayed by 15 min
359.26MMarket Cap
LossP/E TTM
More Details of SelectQuote Inc Company
SelectQuote, Inc. provides a technology-enabled, direct-to-consumer (DTC) distribution and engagement platform for selling insurance policies and healthcare services. The Company has four core business lines: SelectQuote Senior, SelectQuote Healthcare Services, SelectQuote Life, and SelectQuote Auto and Home. SelectQuote’s Senior division sells Medicare Advantage, Medicare Supplement, Medicare Part D, and other ancillary senior health insurance related products. SelectQuote Healthcare Services comprises the SelectRx Pharmacy, a specialized medication management pharmacy, and Population Health which proactively connects its members with healthcare services that fit each member's healthcare needs. SelectQuote’s Auto & Home division primarily sells non-commercial auto and home, property and casualty insurance products. SelectQuote’s Life division sells term life, final expense, and other ancillary products. SelectRx is a Patient-Centered Pharmacy Home (PCPH) accredited pharmacy.
Company Info
Ticker SymbolSLQT
Company nameSelectQuote Inc
IPO dateMay 21, 2020
CEOMr. Timothy Robert (Tim) Danker
Number of employees1335
Security typeOrdinary Share
Fiscal year-endMay 21
Address6800 West 115Th Street
CityOVERLAND PARK
Stock exchangeNYSE Consolidated
CountryUnited States of America
Postal code66211
Phone19132741994
Websitehttps://ir.selectquote.com/investor-home/default.aspx
Ticker SymbolSLQT
IPO dateMay 21, 2020
CEOMr. Timothy Robert (Tim) Danker
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Robert Clay (Bob) Grant
Mr. Robert Clay (Bob) Grant
President
President
4.32M
+10.97%
Mr. Timothy Robert (Tim) Danker
Mr. Timothy Robert (Tim) Danker
Chief Executive Officer, Director
Chief Executive Officer, Director
2.63M
+21.12%
Ms. Denise L. Devine, CPA
Ms. Denise L. Devine, CPA
Independent Director
Independent Director
318.58K
+1.27%
Dr. Kavita K. Patel, M.D.
Dr. Kavita K. Patel, M.D.
Independent Director
Independent Director
310.58K
+43.99%
Mr. Ryan Moore Clement
Mr. Ryan Moore Clement
Chief Financial Officer
Chief Financial Officer
304.70K
+95.99%
Ms. Sarah Anderson
Ms. Sarah Anderson
Executive Vice President - Pharmacy Services
Executive Vice President - Pharmacy Services
51.63K
+586.59%
Mr. Sloan Bohlen
Mr. Sloan Bohlen
Investor Relations
Investor Relations
--
--
Mr. William Thomas Grant, III
Mr. William Thomas Grant, III
Chief Operating Officer
Chief Operating Officer
--
--
Ms. Stephanie D. Fisher
Ms. Stephanie D. Fisher
Chief Accounting Officer
Chief Accounting Officer
--
--
Mr. Raymond F. Weldon
Mr. Raymond F. Weldon
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Robert Clay (Bob) Grant
Mr. Robert Clay (Bob) Grant
President
President
4.32M
+10.97%
Mr. Timothy Robert (Tim) Danker
Mr. Timothy Robert (Tim) Danker
Chief Executive Officer, Director
Chief Executive Officer, Director
2.63M
+21.12%
Ms. Denise L. Devine, CPA
Ms. Denise L. Devine, CPA
Independent Director
Independent Director
318.58K
+1.27%
Dr. Kavita K. Patel, M.D.
Dr. Kavita K. Patel, M.D.
Independent Director
Independent Director
310.58K
+43.99%
Mr. Ryan Moore Clement
Mr. Ryan Moore Clement
Chief Financial Officer
Chief Financial Officer
304.70K
+95.99%
Ms. Sarah Anderson
Ms. Sarah Anderson
Executive Vice President - Pharmacy Services
Executive Vice President - Pharmacy Services
51.63K
+586.59%
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Commission
193.16M
47.32%
Pharmacy revenue
185.27M
45.39%
Production bonus and other revenue
29.73M
7.28%
No Data
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Commission
193.16M
47.32%
Pharmacy revenue
185.27M
45.39%
Production bonus and other revenue
29.73M
7.28%
Shareholding Stats
Updated: 8 hours ago
Updated: 8 hours ago
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Brookside Equity Partners LLC
10.24%
BlackRock Institutional Trust Company, N.A.
5.33%
The Vanguard Group, Inc.
4.75%
Abrams Bison Investments, L.L.C.
4.58%
Mariner Wealth Advisors
3.64%
other
71.46%
Shareholders
Shareholders
Proportion
Brookside Equity Partners LLC
10.24%
BlackRock Institutional Trust Company, N.A.
5.33%
The Vanguard Group, Inc.
4.75%
Abrams Bison Investments, L.L.C.
4.58%
Mariner Wealth Advisors
3.64%
other
71.46%
Shareholder Types
Shareholders
Proportion
Investment Advisor
20.04%
Investment Advisor/Hedge Fund
12.58%
Individual Investor
11.53%
Private Equity
10.24%
Hedge Fund
7.50%
Research Firm
2.11%
Corporation
0.63%
Pension Fund
0.43%
Bank and Trust
0.39%
other
34.56%
Institutional Shareholding
Updated: Tue, Aug 5
Updated: Tue, Aug 5
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
332
110.44M
63.96%
+4.81M
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
No Data
View more
Related ETFs
Updated: Wed, Aug 6
Updated: Wed, Aug 6
Name
Proportion
iShares FinTech Active ETF
1.05%
iShares Micro-Cap ETF
0.07%
Avantis US Small Cap Equity ETF
0.05%
Fidelity Enhanced Small Cap ETF
0.05%
Invesco RAFI US 1500 Small-Mid ETF
0.02%
iShares Russell 2000 Growth ETF
0.02%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.02%
Avantis US Small Cap Value ETF
0.02%
iShares US Small-Cap Equity Factor ETF
0.01%
Global X Russell 2000 ETF
0.01%
View more
iShares FinTech Active ETF
Proportion1.05%
iShares Micro-Cap ETF
Proportion0.07%
Avantis US Small Cap Equity ETF
Proportion0.05%
Fidelity Enhanced Small Cap ETF
Proportion0.05%
Invesco RAFI US 1500 Small-Mid ETF
Proportion0.02%
iShares Russell 2000 Growth ETF
Proportion0.02%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proportion0.02%
Avantis US Small Cap Value ETF
Proportion0.02%
iShares US Small-Cap Equity Factor ETF
Proportion0.01%
Global X Russell 2000 ETF
Proportion0.01%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
